Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review
Clinicians should consider CMT in the male lung or liver cancer patients with cardiac symptoms. Abnormal coagulation, impaired heart function, tumor location, and age are key prognostic factors for CMT. Surgical intervention is the preferred treatment option, as it significantly prolongs median survival.
Authors
- Lingyun Luo
- Zhen He (ORCID: https://orcid.org/0000-0001-6302-6556)
- Liang‐In Lin (ORCID: https://orcid.org/0000-0002-3561-1093)
- Tianshu Yang (ORCID: https://orcid.org/0000-0002-0772-9123)
- Xuelian Luo
Institutions
- Army Medical University (CN)
- Third People 's Hospital of Chongqing (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Huazhong University of Science and Technology Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- World Journal of Cardiology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.4330/wjc.v17.i2.101851
- Primary Topic
- Cardiac tumors and thrombi
- Type
- article
- Field-Weighted Citation Impact
- 0.00